FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1535488907> ?p ?o ?g. }

• W1535488907 endingPage "3679" @default.
• W1535488907 startingPage "3669" @default.
• W1535488907 abstract "// Qingyu Zhang 1, * , Caijie Lu 1, * , Tao Fang 1 , Yongcun Wang 2 , Wenhua Hu 3 , Jie Qiao 1 , Bin Liu 1 , Jie Liu 1 , Nianping Chen 1 , Mingyi Li 1 , Runzhi Zhu 1 1 Laboratory of Hepatobiliary Surgery of Affiliated Hospital of Guangdong Medical College, Zhanjiang Key Laboratory of Hepatobiliary Diseases, Zhanjiang 524001, China 2 Oncology Center, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China 3 Department of Pathology, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China * These authors contributed equally to this work Correspondence to: Mingyi Li, e-mail: hepatolab@163.com Nianping Chen, e-mail: npc88@163.com Runzhi Zhu, e-mail: hepatolab@gmail.com Keywords: Notch3, Beta-catenin, cancer stem cells, hepatocellular carcinoma Received: August 07, 2014      Accepted: December 11, 2014      Published: January 21, 2015 ABSTRACT The Notch signaling pathway plays a role in cell proliferation, differentiation. Emerging data have revealed aberrant Notch3 expression in hepatocellular carcinoma (HCC). However, whether Notch3 plays a role in tumorigenesis or tumor progression is unclear. In this study, we found that over 71.8% of the cases studied had high Notch3 expression levels ( n = 32); Notch3 expression positively correlated with alpha-fetoprotein (AFP) levels ( p = 0.0311) and negatively correlated with the differentiation grade ( p = 0.042). We demonstrated that the patients with higher levels of Notch3 expression commonly had a poor prognosis. We discovered that Notch3 expression is inversely correlated with β-catenin content but positively associated with the protein level of Nanog. In parallel, we found that Notch3 attenuation resulted in the upregulation of β-catenin and the downregulation of Nanog in the hepatoma cell lines QGY7701 and HepG2. The downregulation of Notch3 enhanced the sensitivity to cisplatin in the QGY7701 and HepG2 cells and inhibited the ability of QGY7701 cells to form tumors. The Notch3-positive cells had higher levels of aldehyde dehydrogenase (ALDH) activity, and a tendency to differentiate into Notch3-negative cells. In conclusion, our study demonstrated that Notch3 plays a role in modulating the stemness of tumor cells via the inactivation of the Wnt/β-catenin pathway." @default.
• W1535488907 created "2016-06-24" @default.
• W1535488907 creator A5003517853 @default.
• W1535488907 creator A5006090135 @default.
• W1535488907 creator A5019158214 @default.
• W1535488907 creator A5034180607 @default.
• W1535488907 creator A5040082411 @default.
• W1535488907 creator A5048826252 @default.
• W1535488907 creator A5051921050 @default.
• W1535488907 creator A5055188575 @default.
• W1535488907 creator A5063854822 @default.
• W1535488907 creator A5067819286 @default.
• W1535488907 creator A5085352453 @default.
• W1535488907 date "2015-02-11" @default.
• W1535488907 modified "2023-10-06" @default.
• W1535488907 title "Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma" @default.
• W1535488907 cites W1887724877 @default.
• W1535488907 cites W1984475127 @default.
• W1535488907 cites W2001780798 @default.
• W1535488907 cites W2004916479 @default.
• W1535488907 cites W2005609755 @default.
• W1535488907 cites W2009568610 @default.
• W1535488907 cites W2011842366 @default.
• W1535488907 cites W2018527149 @default.
• W1535488907 cites W2029634531 @default.
• W1535488907 cites W2051935450 @default.
• W1535488907 cites W2066307520 @default.
• W1535488907 cites W2068424305 @default.
• W1535488907 cites W2073271124 @default.
• W1535488907 cites W2087564721 @default.
• W1535488907 cites W2088969512 @default.
• W1535488907 cites W2099797262 @default.
• W1535488907 cites W2102085111 @default.
• W1535488907 cites W2102394111 @default.
• W1535488907 cites W2126697949 @default.
• W1535488907 cites W2148625728 @default.
• W1535488907 cites W2149226292 @default.
• W1535488907 cites W2152244674 @default.
• W1535488907 cites W2159607376 @default.
• W1535488907 cites W2328421677 @default.
• W1535488907 doi "https://doi.org/10.18632/oncotarget.2898" @default.
• W1535488907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4414145" @default.
• W1535488907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25668819" @default.
• W1535488907 hasPublicationYear "2015" @default.
• W1535488907 type Work @default.
• W1535488907 sameAs 1535488907 @default.
• W1535488907 citedByCount "45" @default.
• W1535488907 countsByYear W15354889072015 @default.
• W1535488907 countsByYear W15354889072016 @default.
• W1535488907 countsByYear W15354889072017 @default.
• W1535488907 countsByYear W15354889072018 @default.
• W1535488907 countsByYear W15354889072019 @default.
• W1535488907 countsByYear W15354889072020 @default.
• W1535488907 countsByYear W15354889072021 @default.
• W1535488907 countsByYear W15354889072022 @default.
• W1535488907 countsByYear W15354889072023 @default.
• W1535488907 crossrefType "journal-article" @default.
• W1535488907 hasAuthorship W1535488907A5003517853 @default.
• W1535488907 hasAuthorship W1535488907A5006090135 @default.
• W1535488907 hasAuthorship W1535488907A5019158214 @default.
• W1535488907 hasAuthorship W1535488907A5034180607 @default.
• W1535488907 hasAuthorship W1535488907A5040082411 @default.
• W1535488907 hasAuthorship W1535488907A5048826252 @default.
• W1535488907 hasAuthorship W1535488907A5051921050 @default.
• W1535488907 hasAuthorship W1535488907A5055188575 @default.
• W1535488907 hasAuthorship W1535488907A5063854822 @default.
• W1535488907 hasAuthorship W1535488907A5067819286 @default.
• W1535488907 hasAuthorship W1535488907A5085352453 @default.
• W1535488907 hasBestOaLocation W15354889071 @default.
• W1535488907 hasConcept C104317684 @default.
• W1535488907 hasConcept C107459253 @default.
• W1535488907 hasConcept C121608353 @default.
• W1535488907 hasConcept C126322002 @default.
• W1535488907 hasConcept C143998085 @default.
• W1535488907 hasConcept C145103041 @default.
• W1535488907 hasConcept C207701140 @default.
• W1535488907 hasConcept C2778019345 @default.
• W1535488907 hasConcept C502942594 @default.
• W1535488907 hasConcept C54355233 @default.
• W1535488907 hasConcept C555283112 @default.
• W1535488907 hasConcept C71924100 @default.
• W1535488907 hasConcept C86803240 @default.
• W1535488907 hasConceptScore W1535488907C104317684 @default.
• W1535488907 hasConceptScore W1535488907C107459253 @default.
• W1535488907 hasConceptScore W1535488907C121608353 @default.
• W1535488907 hasConceptScore W1535488907C126322002 @default.
• W1535488907 hasConceptScore W1535488907C143998085 @default.
• W1535488907 hasConceptScore W1535488907C145103041 @default.
• W1535488907 hasConceptScore W1535488907C207701140 @default.
• W1535488907 hasConceptScore W1535488907C2778019345 @default.
• W1535488907 hasConceptScore W1535488907C502942594 @default.
• W1535488907 hasConceptScore W1535488907C54355233 @default.
• W1535488907 hasConceptScore W1535488907C555283112 @default.
• W1535488907 hasConceptScore W1535488907C71924100 @default.
• W1535488907 hasConceptScore W1535488907C86803240 @default.
• W1535488907 hasIssue "6" @default.
• W1535488907 hasLocation W15354889071 @default.
• W1535488907 hasLocation W15354889072 @default.

• next